E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR

Relative Value

There is not enough data to reliably calculate the relative value of EPE.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPE Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
1 927.2
Median 5Y
1 877.3
Industry
7.9
Forward
1 463.5
vs History
vs Industry
Median 3Y
-491.8
Median 5Y
-479
Industry
23.7
Forward
-364.9
vs History
vs Industry
Median 3Y
-489.7
Median 5Y
-477
Industry
22
vs History
vs Industry
Median 3Y
-442.9
Median 5Y
-431.5
Industry
24.3
vs History
vs Industry
Median 3Y
-5 037
Median 5Y
-4 906.5
Industry
3.3
vs History
vs Industry
Median 3Y
1 928.8
Median 5Y
1 878.9
Industry
8.2
Forward
1 464.6
vs History
vs Industry
Median 3Y
2 552.9
Median 5Y
2 486.8
Industry
10.2
vs History
vs Industry
Median 3Y
-535.5
Median 5Y
-521.7
Industry
6.1
vs History
vs Industry
Median 3Y
-521.2
Median 5Y
-507.7
Industry
6.5
vs History
vs Industry
Median 3Y
-490.1
Median 5Y
-477.5
Industry
7.9
vs History
vs Industry
Median 3Y
-489.5
Median 5Y
-476.8
Industry
6.3
vs History
vs Industry
Median 3Y
891
Median 5Y
868
Industry
5.7

Multiples Across Competitors

EPE Competitors Multiples
Epizyme Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.4 -532.4 -579.7 -564.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 766 261.7 -160 486 -194 881.2 -192 657.4
US
Abbvie Inc
NYSE:ABBV
406B USD 6.8 172.9 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
176.7B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
152.7B USD 5.2 18.8 12.6 12.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.5B USD 9.9 31.4 23.1 24.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.5B USD 5.7 17.8 17 19.3
AU
CSL Ltd
ASX:CSL
83.6B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53B USD 16.5 1 215.9 164 198.8
NL
argenx SE
XBRU:ARGX
43.8B EUR 14.3 33.6 57.9 59.5
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.6 -66.4 -60
P/S Multiple
Revenue Growth P/S to Growth
US
E
Epizyme Inc
F:EPE
Average P/S: 3 069 857.7
2 086.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 766 261.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.8
9%
0.8
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
6%
1
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.5
46%
0.4
NL
argenx SE
XBRU:ARGX
14.3
49%
0.3
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
P/E Multiple
Earnings Growth PEG
US
E
Epizyme Inc
F:EPE
Average P/E: 191.8
Negative Multiple: -532.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 486 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172.9
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.8
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 215.9
N/A N/A
NL
argenx SE
XBRU:ARGX
33.6
40%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
E
Epizyme Inc
F:EPE
Average EV/EBITDA: 40.3
Negative Multiple: -579.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 881.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
164
N/A N/A
NL
argenx SE
XBRU:ARGX
57.9
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
E
Epizyme Inc
F:EPE
Average EV/EBIT: 46.5
Negative Multiple: -564.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 657.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
16%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.3
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.8
N/A N/A
NL
argenx SE
XBRU:ARGX
59.5
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60 N/A N/A